the aid library

LIST OPTIONS

Filter

8049

Sort by:

Direction:

Download (630)

View PDF (1423)

Syria Crisis: Addressing Regional Mental Health Needs and Gaps in the Context of the Syria Crisis

International Medical Corps (2015) CC

The report reveals weak national mental health services overburdened by the demands placed on them by the Syria crisis. Health facilities which previously provided integrated mental health services in Syria have themselves become casualties of war, with most either destroyed, damaged or not function... more

Download (120)

View PDF (1006)

Childhood tuberculosis in Dushanbe, Tajikistan

Kadridin Pirov, Umriniso Sirojiddinova, Oktam Bobokhojaev, et al. (2016) CC

Public health Panoram, Vol.2 Issue 1 March 2016

Download (125)

View PDF (198)

Proposed guidelines for the management of nodding syndrome

Idro R, Musubire K A, Byamah Mutamba B; et al. World Health Organization WHO (2013) CC

African Health Sciences 2013; 13(2): 219 - 232 http://dx.doi.org/10.4314/ahs.v13i2.4

Download (148)

View PDF (237)

The Condition of the Girl Child worldwide - Fifth Edition

Indefes - Terre des Hommes (2016) C1

In the last five years, i.e. how old turned the Campaign “Indifesa” (Defenceless) in 2016, that was launched by Terre des Hommes in 2012, the world has become smaller. One can actually say that the derangements following the Arab Spring in 2011 reshuffled what is stable and what produces instabi... more

Download (377)

View PDF (565)

CBR Training Manual
recommended

LIGHT FOR THE WORLD (2011) C1

LIGHT FOR THE WORLD is a European confederation of national development NGOs committed to saving eyesight, improving the quality of life and advocating for the rights of person with disabilities in the underprivileged regions of our world. The guidelines reflect both the ongoing developments within ... more

Download (233)

View PDF (419)

Estimating Cost of National Strategic Plan for Newborn and Child Health Development (2015-2018)

The Republic of the Union of Myanmar, Ministry of Health, Department of Health, Child Health Division World Health Organization (WHO), Country Office for Myanmar (2015) C1

No publication year indicated
The cost of newborn and child health interventions were estimated considering several different angles. At the first attempt, the cost of implementing all newborn and child health interventions packaged as antenatal, Intra natal, Essential newborn care, Care of sic... more

Download (291)

View PDF (496)

National Strategic Plan for Newborn and Child Health Development (2015-2018)

The Republic of the Union of Myanmar, Ministry of Health, Department of Health, Child Health Division World Health Organization (WHO), Country Office for Myanmar (2015) C_WHO

No publication year indicated
The specific objectives of the plan are to:
- Scale up evidence-based, cost effective interventions through effective strategies within a HSS approach and provide equitable coverage with quality.
- Reduce neonatal mortality by improved home-based newborn ... more

Download (119)

View PDF (832)

RWANDA: UNICEF INFO BY COUNTRY

United Nations Children's Fund (UNICEF) (2018)

Accessed June 2018 | UNICEF Data: Monitoring the Situation of Children and Women

Download (125)

View PDF (204)

Start Free Stay Free AIDS Free - 2017 progress report

Joint United Nations Programme on HIVAIDS (UNAIDS) (2017) C1

This progress report reflects achievements made during the first year of implementation (through December 2016), as countries have taken actions in line with new or existing national strategies. The most recent data on country progress in 2016 are based on country-reported data and country-developed... more

Download (342)

View PDF (268)

Acting on the call

USAID (2018) C1

A Focus on the Journey to Self-Reliance for Preventing Child and Maternal Deaths . June 2018
The 2018 Acting on the Call report focuses on 25 countries’ journeys to self-reliance for preventing child and maternal deaths. Self-reliance is a country’s ability to finance and implement solution... more

Download (120)

View PDF (169)

Retard de croissance ou prise de poids hésitante en contexte de soin de santé primaire

A. Berg IACAPAP (2012) C2

Psychiatrie de l'enfant Chapitre B.2 Edition en français Traduction : Claire Rousseau Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA

Download (801)

View PDF (1538)

Community-based rehabilitation (CBR) for people with disabilities in Nepal: an overview

Padmani Mendi & Romi Gurung Handicap International (2007) C2

This study examines over 20 years of CBR implementation in Nepal. It includes an overview of CBR interventions, provides analysis of approaches and activities in terms of impact and sustainability and makes recommendations for future developments in CBR. This resource is useful for people interested... more

Download (203)

View PDF (318)

African Disability Rights Yearbook 2014

Pretoria University Law Press (PULP) (2014) C2

Volume 2 - 2014

Download (75)

View PDF (157)

Interim Guidance for COVID-19 prevention and control in schools
recommended

Bender L. Unicef, WHO, IASC (Inter-Agency Standing Commitee) (2020) C_UNICEF

The protection of children and educational facilities is particularly important. Precautions are necessary to prevent the potential spread of COVID-19 in school settings; however, care must also be taken to avoid stigmatizing students and staff who may have been exposed to the virus. It is important... more

Download (74)

View PDF (135)

Policy Brief: The impact of COVID-19 on older persons

United Nations (2020) C2

The COVID-19 pandemic is causing untold fear and suffering for older people across the world. As of 26 April, the virus itself has already taken the lives of some 193,710 people, and fatality rates for those over 80 years of age is five times the global average. As the virus spreads rapidly to devel... more

Download (144)

View PDF (152)

Virtual cold chain equipment industry consultation – November 2020

UN Children's Fund UNICEF; GAVI (2020) C_UNICEF

Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID-19 vaccines.

Download (155)

View PDF (165)

MAMI Care Pathway Package

MAMI, Irish Aid, Eleanor Crook Foundation (2020) CC

MAMI refers to the management of small and nutritionally at risk infants under six months of age (infants u6m) and their mothers.

Download (129)

View PDF (161)

La COVID-19 chez les enfants et les adolescents : document d’information scientifique, 29 septembre 2021

Organisation Mondiale de la Santé OMS (2021) C_WHO

Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t... more

Download (137)

View PDF (175)

Public policy challenges in light of the care crisis: The impact of the pandemic on households with children and adolescents led by women

Guzmán M. National Directorate for Economy, Equality and Gender and UNICEF (2021) C_UNICEF

The crisis caused by the COVID-19 pandemic exacerbated preexisting structural economic inequalities, and had a disproportionate impact on informal workers, especially on women and young people, who lost jobs and income. The situation was even more difficult for single-parent households led by women,... more

Download (245)

View PDF (329)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

CBR Training Manual recommended

Interim Guidance for COVID-19 prevention and control in schools recommended

CBR Training Manual
recommended

Interim Guidance for COVID-19 prevention and control in schools
recommended